Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Geall

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Opinion in Immunology|May 31, 2016
Recent innovations in mRNA vaccinesJeffrey B Ulmer, Andrew J Geall
Expert Review of Vaccines|January 13, 2015
Introduction to RNA-based vaccines and therapeuticsAndrew J Geall, Jeffrey B Ulmer
Expert Opinion on Drug Discovery|November 17, 2022
Vaccines on demand, part II: future realityAndrew J Geall, Zoltan Kis, Jeffrey B Ulmer
Vaccines|February 2, 2021
An Update on Self-Amplifying mRNA Vaccine DevelopmentAnna K Blakney, Shell Ip, Andrew J Geall
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Measurement of polyamine pKa valuesIan S Blagbrough, Abdelkader A Metwally, Andrew J Geall
Bioconjugate Chemistry|May 16, 2002
Efficient calf thymus DNA condensation upon binding with novel bile acid polyamine amidesAndrew J Geall, Dima Al-Hadithi, Ian S Blagbrough
Seminars in Immunology|June 6, 2013
RNA: the new revolution in nucleic acid vaccinesAndrew J Geall, Christian W Mandl, Jeffrey B Ulmer
Expert Opinion on Drug Discovery|January 14, 2015
Vaccines 'on demand': science fiction or a future realityJeffrey B Ulmer, Monique K Mansoura, Andrew J Geall
Cancer Gene Therapy|February 23, 2022
Next generation self-replicating RNA vectors for vaccines and immunotherapiesParinaz Aliahmad, Shigeki J Miyake-Stoner, Andrew J Geall, et al.
Expert Opinion on Drug Delivery|March 27, 2014
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccinesRaquel P Deering, Sushma Kommareddy, Jeffrey B Ulmer, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Opinion in Immunology|May 31, 2016
Recent innovations in mRNA vaccinesJeffrey B Ulmer, Andrew J Geall
Expert Review of Vaccines|January 13, 2015
Introduction to RNA-based vaccines and therapeuticsAndrew J Geall, Jeffrey B Ulmer
Expert Opinion on Drug Discovery|November 17, 2022
Vaccines on demand, part II: future realityAndrew J Geall, Zoltan Kis, Jeffrey B Ulmer
Vaccines|February 2, 2021
An Update on Self-Amplifying mRNA Vaccine DevelopmentAnna K Blakney, Shell Ip, Andrew J Geall
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Measurement of polyamine pKa valuesIan S Blagbrough, Abdelkader A Metwally, Andrew J Geall
Bioconjugate Chemistry|May 16, 2002
Efficient calf thymus DNA condensation upon binding with novel bile acid polyamine amidesAndrew J Geall, Dima Al-Hadithi, Ian S Blagbrough
Seminars in Immunology|June 6, 2013
RNA: the new revolution in nucleic acid vaccinesAndrew J Geall, Christian W Mandl, Jeffrey B Ulmer
Expert Opinion on Drug Discovery|January 14, 2015
Vaccines 'on demand': science fiction or a future realityJeffrey B Ulmer, Monique K Mansoura, Andrew J Geall
Cancer Gene Therapy|February 23, 2022
Next generation self-replicating RNA vectors for vaccines and immunotherapiesParinaz Aliahmad, Shigeki J Miyake-Stoner, Andrew J Geall, et al.
Expert Opinion on Drug Delivery|March 27, 2014
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccinesRaquel P Deering, Sushma Kommareddy, Jeffrey B Ulmer, et al.
Pageof 3